NEW YORK, Jan. 26 (GenomeWeb News) - Health Discovery said today that it has signed an agreement acquiring the first option to obtain the exclusive worldwide rights to commercialize prostate cancer biomarkers or pathways identified by the company as part of a collaboration with the University of Texas, MD Anderson Cancer Center.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.